See also this year's filing and all EDGAR filings for this company.
PDF Report 0001443863_2023_Biocorrx_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Liabilities', 'value': 10341411, 'size_variable': 'Assets', 'size_value': 388887, 'ratio': 26.6, 'threshold': 20} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001443863')"} |
Graph
Absolute values for 0001443863, Biocorrx Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 270,406 |
| 2 | AssetsCurrent | 316,910 |
| 3 | PropertyPlantAndEquipment | 76,572 |
| 4 | remainder_Assets | 102,706 |
| 5 | LongTermLiabilities | 181,328 |
| 6 | LiabilitiesCurrent | 5,363,792 |
| 7 | remainder_Liabilities | 3,423,205 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 3,409,649 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 27,450 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 1,459,458 |
| 16 | remainder_Expenses | 15,279 |
| 17 | remainder_Revenues | 213,841 |
| 18 | remainder_NetIncome | 321,163 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 766,594 |
| 1 | Liabilities | 8,968,325 |
| 2 | Expenses | 4,911,836 |
| 3 | Revenues | 213,841 |
| 4 | StockholdersEquity | -8,201,731 |
| 5 | NetIncome | -4,376,832 |
| 6 | ComprehensiveNetIncome | -4,376,832 |
| 7 | BaseVar | 7,590,880 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.34 |
| 9 | EconomicCapitalRatio | 0.0855 |
Edgar->Model Mapping
Feature Distribution
Change over Time
